Tapiero Jacques

Average Profitability
7.09%
Insider Buys Quantity
2
Insider Buys Sum
$91,733.38
Insider Sells Quantity
15
Insider Sells Sum
$5.92M

Insider Activity of Tapiero Jacques

According to the SEC Form 4 filings, Tapiero Jacques, being in a position of

  1. director at McCormick & Company, Incorporated,
    Đľver the last 12 months, has bought 0 shares, and sold 10000 shares for $778,375,
    over all time since 2014-01-31, has bought 1310 shares for $91,733, and sold 30000 shares for $3.8M.

The largest purchase of all time was on 2014-06-30 and amounted to 1000 shares of McCormick & Company, Incorporated for $71,770.

The largest sale of all time was on 2020-08-13 and amounted to 10000 shares of McCormick & Company, Incorporated for $1.99M.

Biography of Tapiero Jacques

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$778,3752100

Comparison of Insiders on Amount of Buys and Sells

2024-11-11SaleMcCormick & Company, Incorporated
MKC
director
5,000
0.0019%
$77.34$386,703+0.95%
2024-11-04SaleMcCormick & Company, Incorporated
MKC
director
5,000
0.0019%
$78.33$391,672-0.64%
2023-07-26SaleMcCormick & Company, Incorporated
MKC
director
5,000
0.0019%
$89.88$449,422-21.86%
2020-08-13SaleMcCormick & Company, Incorporated
MKC
director
10,000
0.0074%
$199.49$1.99M-9.57%
2019-08-16SaleMcCormick & Company, Incorporated
MKC
director
5,000
0.0026%
$116.31$581,548-2.2%
2014-06-30PurchaseMcCormick & Company, Incorporated
MKC
director
1,000
0.0008%
$71.77$71,770+3.42%
2014-01-31PurchaseMcCormick & Company, Incorporated
MKC
director
310
0.0002%
$64.40$19,963+10.76%
2013-07-29SaleEli Lilly and Company
LLY
SVP&Pres., Emerging Markets
7,500
0.0007%
$53.74$403,050+2.68%
2013-01-30SaleEli Lilly and Company
LLY
SVP&Pres., Emerging Markets
15,000
0.0013%
$54.14$812,100-0.51%
2012-06-14SaleEli Lilly and Company
LLY
SVP&Pres., Emerging Markets
2,125
0.0002%
$41.60$88,400+22.3%
2012-05-14SaleEli Lilly and Company
LLY
SVP&Pres., Emerging Markets
2,000
0.0002%
$41.04$82,080+21.33%
2012-04-17SaleEli Lilly and Company
LLY
SVP&Pres., Emerging Markets
2,000
0.0002%
$40.00$80,000+22.42%
2012-03-12SaleEli Lilly and Company
LLY
SVP&Pres., Emerging Markets
2,000
0.0002%
$39.60$79,200+19.47%
2011-11-18SaleEli Lilly and Company
LLY
SVP&Pres., Emerging Markets
5,000
0.0004%
$36.88$184,400+13.77%
2011-03-04SaleEli Lilly and Company
LLY
SVP&Pres., Emerging Markets
5,000
0.0004%
$34.50$172,500+10.99%
2010-03-11SaleEli Lilly and Company
LLY
SVP&Pres., Emerging Markets
4,000
0.0004%
$35.41$141,625+1.04%
2010-02-17SaleEli Lilly and Company
LLY
SVP&Pres., Emerging Markets
2,000
0.0002%
$34.35$68,700+4.95%
Total: 17
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.